Precision genomics for hereditary cancer with adaptive sampling
The Oxford Nanopore Hereditary Cancer Panel offers comprehensive germline variant analysis across 258 cancer predisposition genes. The panel uses adaptive sampling: a fast and flexible on-sequencer target enrichment methodology. No lengthy library preparation, baits, or primers required.
Why choose the Oxford Nanopore Hereditary Cancer Panel?
One consolidated assay for deeper genomic and epigenomic insight
Rapid, streamlined sequencing — no batching required
Flexible enrichment. Scalable sequencing. Built for every lab.
)
Recommended device for the Hereditary Cancer Panel
PromethION 24
The PromethION 24 (P24) is a high-throughput sequencing device featuring 24 independent flow cells positions, allowing users to sequence multiple samples simultaneously or flexibly scale their experiments.
)
)
Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel
This application note highlights how the HCP provides a scalable, accessible, and cost-effective solution for comprehensive analysis of hereditary cancer genes, with the potential to advance precision oncology.
